Down-regulation of hepatic LDL receptor expression in experimental nephrosis

Kidney International

Volumn 50, Issue 3, 1996, Pages 887-893

  Vaziri, Nosratola D ^a,b   Liang, Kai Hui ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; MALE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

EID: 0029785877     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.388     Document Type: Article

References (25)

1. GARBER DW, GOTTLIEB BA, MARSH JB, SPARKS CE: Catabolism of very low density lipoproteins in experimental nephrosis. J Clin Invest 74:1375-1383, 1984
2. MARSH JB: Lipoprotein metabolism in experimental nephrosis. J Lipid Rex 25:1614-1623, 1984
3. STAPRANS I, FEETS JM, COUSER WG: Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats. Metabolism 36:496-501, 1987
4. KAYSEN GA: Hyperlipidemia of the nephrotic syndrome. Kidney Int 39(Suppl 31):S8-S15, 1991
5. MOORHEAD JF, WHEELER DC, VARGHESE Z: Glomerular structure and lipids in progressive renal disease. Am J Med 87:5-12N-5-20N, 1989
6. DIAMOND JR, KARNOVSKY MJ: Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32:671-677, 1987
7. DIAMOND JR: Hyperlipidemia of nephrosis: Pathophysiologic role in progressive glomerular disease. Am J Med 87:5-25N-5-29N, 1989
8. AVRAM MM: Cholesterol and lipids in renal disease. Am J Med 87:5-1N-5-2N, 1989
9. WARWICK GL, CASLAKE MJ, BOULTON-JONES JM, DAGEN M, PACKARD CJ, SHEPHERD J: Low-density lipoprotein metabolism in the nephrotic syndrome. Metabolism 39:187-192, 1990
10. WARWICK GL. PACKARD CJ, DEMANT T, BEDFORD DK, BOULTON-JONES JM, SHEPHERD J: Metabolism of apoprotein B-containing lipoproteins in patients with nephrotic range proteinuria. Kidney Int 40:129-138, 1991
11. DIETSCHY JM: Experimental mechanism: Regulation of plasma LDL cholesterol. Am J Clin Nutr 62:679S-688S, 1995
12. SPADY DK, HILHEIMER DW, DIETSCHY JM: Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc Natl Acad Sci USA 80:3499-3503, 1983
13. DIETSCHY JM: An overview of the regulation of cholesterol and LDL metabolism in man and other species, in Liver and Lipid Metabolism, edited by CALANDRA S. CARULLI N, SALVIOLI G. New York, Elsevier Science Publishers, 1984, pp 1-12
14. SPADY DK, TURLEY SD, DIETSCHY JM: Rates of low density lipoprotein uptake and cholesterol synthesis are regulated independently in the liver. J Lipid Res 26:465-472, 1985
15. MYANT NB: Familial hypercholesterolemia: A consequence of LDL-receptor deficiency, in Cholesterol Metabolism, LDL and the LDL Receptor, edited by MYANT NB, London, Academic Press Inc. 1990, pp 401-438
16. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid-guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
17. YAMAMOTO T, DAVIS CG, BROWN MS, SCHNEIDER WJ, CASEY MC, GODSTEIN JL, RUSSELL DW: The human LDL receptor: Acysteinerich protein with multiple Alu sequences in its mRNA. Cell 39:27-38. 1984
18. JOKINEN EV, LANDSCHULZ KT, WYNE KL, HO YK, FRYKMAN PK, HOBBS HH: Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 269:26441-26418, 1994
19. BOHELER KR, CHASSAGNE C, MARTIN X, WISNEWSKY C, SCHWARTZ K: Cardiac expressions of α- and β-myosin heavy chains and sarcomeric α-actin are regulated through transcriptional mechanisms. J Biol Chem 267:12979-12985, 1992
20. GOLPER TA, FEINGOLD KR, FULFORD MH, SIPERSTEIN MD: The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat. J Lipid Res 22:1044-1051, 1986
21. VAZIRI ND, LIANG KH: Gene expression of HMG-CoA reductase during the course of puromycin-induced nephrosis. Kidney Int 48: 1979-1985, 1995
22. LIANG KH, OVEISI F, VAZIRI ND: Gene expression of cholesterol 7α-hydroxylase in the course of puromycin-induced nephrosis. Kidney Int 49:855-860, 1996
23. RUSSELL DW, SETCHELL KDR: Bile acid biosynthesis. Biochemistry 31:4737-4748, 1992
24. COOPER AD: Hepatic lipoprotein and cholesterol metabolism, in Hepatology, edited by ZAKIM D, BOYER T, Philadelphia, WB Saunders, 1989, pp 105-137
25. VLAHCEVIC ZR, HEUMAN DM, HYLEMON PB: Regulation of bile acid synthesis. Hepatology 13:590-600, 1991